RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ascletis Pharma Stock

Ascletis Pharma P/S 2024

Ascletis Pharma P/S

0

Ticker

1672.HK

ISIN

KYG0520K1094

WKN

A2JRKN

As of Nov 19, 2024, Ascletis Pharma's P/S ratio stood at 0, a 0% change from the 32.33 P/S ratio recorded in the previous year.

The Ascletis Pharma P/S history

Ascletis Pharma Aktienanalyse

What does Ascletis Pharma do?

Ascletis Pharma Inc is a bio-pharmaceutical company that was founded in Hong Kong in 2009. The focus of the company is the development and marketing of drugs for the treatment of infectious diseases and cancer. The business model of Ascletis Pharma Inc is based on research and development, as well as sales and marketing activities. The company collaborates closely with academic institutions and clinical researchers to discover and develop new drugs. In recent years, Ascletis has received various awards and recognitions for its products. The company's portfolio includes various areas, such as the treatment of viral infectious diseases like hepatitis B and C infections. They have also developed drugs for the treatment of solid tumors, such as gastric cancer and liver cancer. Alongside medical research, Ascletis also conducts various sales and marketing activities. The company works with partners to market its products worldwide. In summary, Ascletis Pharma Inc is an emerging bio-pharmaceutical company specializing in the development of drugs for the treatment of infectious diseases and cancer. The business model is based on research and development, as well as sales and marketing of products. The company has various divisions and offers a variety of products. Ascletis has experienced continuous growth in recent years and is considered one of the most innovative companies in the industry. Ascletis Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Ascletis Pharma's P/S Ratio

Ascletis Pharma's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Ascletis Pharma's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Ascletis Pharma's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Ascletis Pharma’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Ascletis Pharma stock

What is the price-to-earnings ratio of Ascletis Pharma?

The price-earnings ratio of Ascletis Pharma is currently 0.

How has the price-earnings ratio of Ascletis Pharma changed compared to last year?

The price-to-earnings ratio of Ascletis Pharma has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Ascletis Pharma high compared to other companies?

Yes, the price-to-earnings ratio of Ascletis Pharma is high compared to other companies.

How does an increase in the price-earnings ratio of Ascletis Pharma affect the company?

An increase in the price-earnings ratio of Ascletis Pharma would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Ascletis Pharma affect the company?

A decrease in the price-earnings ratio of Ascletis Pharma would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Ascletis Pharma?

Some factors that influence the price-earnings ratio of Ascletis Pharma are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Ascletis Pharma pay?

Over the past 12 months, Ascletis Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ascletis Pharma is expected to pay a dividend of 0 CNY.

What is the dividend yield of Ascletis Pharma?

The current dividend yield of Ascletis Pharma is .

When does Ascletis Pharma pay dividends?

Ascletis Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ascletis Pharma?

Ascletis Pharma paid dividends every year for the past 0 years.

What is the dividend of Ascletis Pharma?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ascletis Pharma located?

Ascletis Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ascletis Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ascletis Pharma from 11/19/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.

When did Ascletis Pharma pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of Ascletis Pharma in the year 2023?

In the year 2023, Ascletis Pharma distributed 0 CNY as dividends.

In which currency does Ascletis Pharma pay out the dividend?

The dividends of Ascletis Pharma are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ascletis Pharma

Our stock analysis for Ascletis Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ascletis Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.